THE MONEY BEHIND THE MEDICINE


A closer look at the investment history linked to a modern regenerative therapy venture

By Steven Millard | Investigations Desk

Regenerative medicine is often presented as the future of healthcare — a world of innovation, research, and scientific possibility. Yet behind the language of progress sits a financial landscape that many prospective clients may never fully explore.

An examination of corporate records connected to investor Max Robert Lewinsohn, a senior financial figure associated with Wellbeing International Foundation, reveals a business career rooted in high-risk investment ventures rather than clinical medicine. Across several decades, some of those ventures have ended in administration, liquidation, or legal dispute.

While none of these events relate directly to medical procedures, they raise broader questions about transparency when significant private investment intersects with healthcare-adjacent industries.

FROM BALANCE SHEETS TO BIOLOGY

Lewinsohn’s professional background lies in accountancy and international investment structures. Public records show involvement in companies spanning property, energy, and technology — sectors far removed from patient care or clinical research.

Today, however, he occupies a prominent position within an organisation promoting regenerative therapies to an international audience.

For industry observers, this crossover between finance and healthcare highlights an evolving trend: investors increasingly shaping the direction of emerging treatment markets.

AN EARLY CORPORATE SETBACK

One of the earliest chapters in Lewinsohn’s business career involved Dominion International Group Plc, an investment company that later entered administration.

Reports from the period suggest that he stepped down as chairman following disagreements with fellow shareholders, and the company’s financial position deteriorated rapidly soon afterwards. Liabilities were reported to have significantly exceeded assets.

Media coverage at the time referenced internal reviews into the company’s financial disclosures, though no confirmed criminal investigation has been identified in public records.

A SERIES OF HIGH-RISK VENTURES

Following Dominion, Lewinsohn continued to hold senior roles across multiple companies.

Historical reporting also refers to professional disciplinary action linked to disputed transactions overseas, with available records indicating that he was removed from membership of the Institute of Chartered Accountants following related allegations.

Supporters describe these events as the natural ups and downs of venture finance. Critics say they form part of a longer pattern.

WHEN INNOVATION DOESN’T DELIVER

Between the late 1990s and 2000s, Lewinsohn chaired Eneco Inc., an energy-technology company that ultimately filed for bankruptcy.

Legal proceedings following the collapse resulted in court-ordered contributions toward litigation costs connected to company debts.

For governance analysts, Eneco represents another example of an ambitious project struggling to convert investment into long-term stability.

A NEW INSOLVENCY ADDS TO THE TIMELINE

More recent filings show that MicroPower Global Markets Limited, a company linked to Lewinsohn’s later business activities, has entered Creditors’ Voluntary Liquidation.

Documentation indicates that at the point of winding-up the company held minimal cash reserves while creditor claims exceeded £246,000, leaving unsecured creditors without a distribution.

Corporate failures are not unusual in emerging sectors. However, investigators say that when viewed alongside earlier ventures, the latest liquidation contributes to a broader narrative that invites closer scrutiny.

WHAT THIS MEANS FOR CLIENT TRUST

This investigation has found no evidence that any of these corporate events directly affected patient treatments or clinical outcomes.

Nevertheless, consumer-protection specialists argue that the financial background of key investors becomes increasingly relevant when individuals commit large sums of money to privately funded therapies.

Transparency, they say, is essential — particularly in industries built on trust and expectation.

RISK, REPUTATION AND RESPONSIBILITY

Supporters maintain that innovation requires risk, and that failure is often part of progress. Critics counter that repeated insolvencies raise legitimate questions about governance — especially when investment moves into healthcare-adjacent markets.

As regulatory scrutiny around regenerative medicine intensifies, the role of financial backers is likely to receive greater attention.

LOOKING AHEAD

If a healthcare-focused venture supported by investors with a history of distressed companies were ever to encounter financial instability, what safeguards would exist for clients?

For now, that question remains unanswered.

But as this investigation suggests, understanding the financial foundations behind emerging medical ventures may be just as important as understanding the science itself.

Comments

Post a Comment

Popular posts from this blog

🌍 Global Pattern of Fraud? An Investigative Exposé

Image
The Rise and Fall of Wellbeing International Foundation Ltd: An Investigative Exposé By Steven Millard - Investigative Correspondent | June 2025 Wellbeing International Foundation Ltd , a company once promoting itself as a pioneer in cutting-edge regenerative medicine, is now at the center of a storm involving allegations of medical fraud, misrepresentation, and international regulatory scrutiny. With operations spanning Bermuda and the UK, the company’s sudden rise—and even swifter fall—offers a cautionary tale about the dangers of unregulated medical therapies and unchecked health claims. https://www.thetruthaboutwellbeingint.org/ 💼  The Promise of “Cell-Free Therapy” Founded in 2015 and registered in Bermuda,  Wellbeing International Foundation Ltd  marketed itself as a leader in “cell-free therapy,” a term used to describe an alleged medical process in which cell secretions from a patient’s own body are extracted, modified, and reinfused to treat a range of condition...
Read more

Wellbeing International Foundation Ltd Crumbling Under Pressure

Image
  📰 Wellbeing International Foundation Ltd Crumbling Under Pressure as Patients Demand Refunds for Fake Treatments By Steven Millard | Investigative Correspondent A growing number of patients across the UK and abroad are now coming forward to demand answers—and  refunds —from  Wellbeing International Foundation Ltd , a self-proclaimed regenerative medicine provider that is increasingly under fire for  selling unproven and possibly fraudulent stem cell therapies . Once cloaked in the promise of cutting-edge science and “natural recovery,” the company is now  crumbling under public pressure  as former clients expose the truth: there were  no medical results, no legal guarantees, and no proper follow-up —only heartbreak, debt, and silence. 💸 The Promise: Hope in a Syringe Wellbeing International Foundation Ltd claimed to offer "cell-free therapy" and other regenerative treatments for serious conditions such as: Autism Multiple sclerosis Parkinson’s Stro...
Read more

Steven Millard: From Victim to Watchdog

Image
  Profile Feature | Behind the Bylines – Health & Ethics Magazine Steven Millard: From Victim to Watchdog One Father’s Journey from Medical Desperation to Investigative Journalism By Editorial Staff For decades,  Steven Millard  was a name known only to the bylines of local papers and online outlets. A lifelong journalist who never needed the spotlight, Millard dedicated his post-high school years to writing, reporting, and telling the stories that mattered. But in 2022, the story that would change his life forever wasn’t one he was chasing—it was one he was living. Steven’s son, born with a rare chronic illness, became the focus of his entire world. Like any devoted father, Millard spent years chasing answers, seeking out top specialists, miracle clinics, and experimental treatments across Europe and beyond. And when traditional medicine ran out of options, he did what many desperate families do: he put his faith—and his finances—into hope. That hope came in the form...
Read more